Immunologic considerations for therapeutic strategies utilizing allogeneic hepatocytes: Hepatocyte‐expressed membrane‐bound major histocompatibility complex class I antigen sensitizes while soluble antigen suppresses the immune response in rats

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Hepatology

• Publication date

  2000-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1053/jhep.2000.19255PMID 11050050
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effective Use of Donor MHC Class I Gene Therapy in Organ Transplantation: Prevention of Antibody-Mediated Hyperacute Heart Allograft Rejection in Highly Sensitized Rat Recipients

  2000cited by this paper
• Patterns of immune responses evoked by allogeneic hepatocytes: evidence for independent co-dominant roles for CD4+ and CD8+ T-cell responses in acute rejection.

  1999cited by this paper
• Prospects of Liver Cell Transplantation and Liver-directed Gene Therapy

  1999cited by this paper
• Hepatocyte transplantation for the treatment of human disease.

  1999cited by this paper
• Expression of soluble allo-MHC class I antigen in vivo suppresses IL-2 production by allo-reactive helper T cells.

  1999cited by this paper
• Hepatocyte gene therapy in a large animal: a neonatal bovine model of citrullinemia.

  1999cited by this paper
• Are dendritic cells the key to liver transplant tolerance?

  1999cited by this paper
• In vivo immunogenicity of purified allogeneic hepatocytes in a murine hepatocyte transplant model.

  1998cited by this paper
• Two distinct forms of soluble MHC class I molecules synthesized by different mechanisms in normal rat cells in vitro.

  1998cited by this paper
• Soluble donor MHC class I antigen inhibits immunologic priming in vitro and in vivo

  1998cited by this paper
• Immunologic suppression mediated by genetically modified hepatocytes expressing secreted allo-MHC class I molecules.

  1998cited by this paper
• Efficacy of anti–intercellular adhesion molecule‐1 immunotherapy on immune responses to allogeneic hepatocytes in mice

  1998cited by this paper
• Nonspecific Inflammation Inhibits Adenovirus-Mediated Pulmonary Gene Transfer and Expression Independent of Specific Acquired Immune Responses

  1998cited by this paper
• Combined liver and pancreas transplantation induces pancreas allograft tolerance.

  1997cited by this paper
• Secreted donor-MHC class I antigen prolongs liver allograft survival and inhibits recipient anti-donor cytotoxic T lymphocyte responses.

  1997cited by this paper
• Immunosuppressive effects of an HLA class I-derived peptide in a rat cardiac allograft model.

  1996cited by this paper
• Liver transplants contribute to their own success

  1996cited by this paper
• Soluble HLA class I molecules induce apoptosis in alloreactive cytotoxic T lymphocytes

  1996cited by this paper
• Immunomodulation by soluble HLA class I.

  1995cited by this paper
• The essential roles of parenchymal tissues and passenger leukocytes in the tolerance induced by liver grafting in rats

  1995cited by this paper
• Soluble form of an HLA-B7 class I antigen specifically suppresses humoral alloimmunization.

  1994cited by this paper
• Organ graft tolerance: the liver effect.

  1994cited by this paper
• Immunity to MHC class I antigen after direct DNA transfer into skeletal muscle.

  1994cited by this paper
• Successful ex vivo gene therapy directed to liver in a patient with familial hypercholesterolaemia

  1994cited by this paper
• Cell migration and chimerism after whole‐organ transplantation: The basis of graft acceptance

  1993cited by this paper
• Interaction of papain‐digested HLA class I molecules with human alloreactive cytotoxic T lymphocytes (CTL)

  1993cited by this paper
• A soluble divalent class I major histocompatibility complex molecule inhibits alloreactive T cells at nanomolar concentrations.

  1993cited by this paper
• Isolation of Hepatocytes by Collagenase Perfusion

  1993cited by this paper
• The effectiveness of pretreatment with soluble or membrane-bound donor class I major histocompatibility complex antigens in the induction of unresponsiveness to a subsequent rat renal allograft.

  1992cited by this paper
• ARGININE‐SPECIFIC SUPPRESSION OF MIXED LYMPHOCYTE CULTURE REACTIVITY BY KUPFFER CELLS—A BASIS OF PORTAL VENOUS TOLERANCE

  1991cited by this paper
• Inhibition of anti-HLA-B7 alloreactive CTL by affinity-purified soluble HLA.

  1991cited by this paper
• Examination of serum class I antigen in liver‐transplanted rats

  1991cited by this paper
• Effect of HLA phenotype and gender on expression of various forms of class I HLA in plasma.

  1991cited by this paper
• Clonal anergy is induced in vitro by T cell receptor occupancy in the absence of proliferation.

  1991cited by this paper
• Specific suppression of allograft rejection by soluble class I antigen and complexes with monoclonal antibody.

  1990cited by this paper
• Protective effects of liver transplantation on a simultaneously transplanted kidney in a highly sensitized patient.

  1990cited by this paper
• Abrogation of the induction of portal venous tolerance in a cardiac transplant model resulting from Kupffer cell inhibition by gadolinium.

  1990cited by this paper
• FREQUENCY OF ALLOANTIGEN‐SPECIFIC T CYTOTOXIC CELLS IN HIGH- AND LOW‐RESPONDER RECIPIENTS OF CLASS I MHC‐DISPARATE HEART ALLOGRAFTS

  1990cited by this paper
• Comparison of in vivo and in vitro immune response to purified hepatocytes.

  1990cited by this paper
• Class I transplantation antigens in solution in body fluids and in the urine. Individuality signals to the environment

  1988cited by this paper
• PRODUCTION OF INDEFINITE RENAL ALLOGRAFT SURVIVAL IN THE RAT BY PRETREATMENT WITH VIABLE AND NONVIABLE HEPATOCYTES OR LIVER MEMBRANE EXTRACTS1

  1988cited by this paper
• Successful sequential liver-kidney transplantation in a patient with performed lymphocytotoxic antibodies.

  1987cited by this paper
• Use of a low-speed, iso-density percoll centrifugation method to increase the viability of isolated rat hepatocyte preparations

  1986cited by this paper
• Transplantation tolerance and immunosuppression following liver grafting in rats.

  1985cited by this paper
• The immunology of experimental liver transplantation in the rat.

  1985cited by this paper
• Characteristics of the Strongly Ia‐Positive Cells in Rat Liver

  1984cited by this paper
• Reversal of transplantation immunity by liver grafting

  1981cited by this paper
• Induction of Immunological Tolerance by Porcine Liver Allografts

  1969cited by this paper
• Improved technique of heart transplantation in rats.

  1969cited by this paper
• The Technique of Free Skin Grafting in Mammals

  1951cited by this paper

• The role of Kupffer cells in hepatic diseases

  2017cites this paper
• XXXII CONGRESO NACIONAL DE LA ASOCIACIÓN ESPAÑOLA PARA EL ESTUDIO DEL HÍGADO

  2016cites this paper
• DNA vaccines for transplantation

  2010cites this paper
• Tolerance in Liver Transplantation

  2009cites this paper
• Minimization or Withdrawal of Immunosuppression in Liver Transplantation

  2007cites this paper
• Immunological aspects of embryo development

  2007cites this paper
• L-CARNITINE AMELIORATES IMMUNOLOGICAL-INDUCED HEPATITIS IN RATS

  2006cites this paper
• Calcium Calmodulin Kinase II , and lck p 56 Mediated : Evidence for the Involvement of HLA Class I Molecules Is Fas Ligand / Fas upon the Engagement of CD 8 by Soluble Apoptosis of Antigen-Specific T Lymphocytes

  2005cites this paper
• Tolerancia inmunolÓgica y trasplante de hígado

  2005cites this paper
• Insulin expressing hepatocytes not destroyed in transgenic NOD mice

  2004cites this paper
• [Immunological tolerance and liver transplantation].

  2004cites this paper
• Immunological tolerance and liver transplantation.

  2004cites this paper
• Erster Nachweis einer in-vivo Langzeitexpression löslicher Spender-MHC Klasse I-Antigene mittels rekombinantem adeno-assoziiertem Virus (rAAV) im Rattenmodell: essentieller Schritt auf dem Weg zur Toleranzinduktion in der Organtransplantation

  2004cites this paper
• Paclitaxel saves rat heart allografts from rejection by inhibition of the primed anti-donor humoral and cellular immune response: implications for transplant patients with cancer

  2003cites this paper
• Paclitaxel saves rat heart allografts from rejection by inhibition of the primed anti‐donor humoral and cellular immune response: implications for transplant patients with cancer

  2003cites this paper
• Eine kontinuierliche Expression löslicher MHC-Spenderantigene mittels adenoviralem Vektor induziert eine Verlängerung der Überlebenszeit von Herztransplantaten im „High“-Respondermodell ACI zu Lewis

  2002cites this paper
• An adenoviral gene transfer system to express high levels of soluble allogeneic MHC class I molecules in vitro and in vivo.

  2002cites this paper
• Lipid rafts, major histocompatibility complex molecules, and immune regulation.

  2002cites this paper
• Expression of high levels of soluble allogeneic major histocompatability complex class I antigen by adenoviral gene transfer strongly inhibits allospecific cytotoxic T lymphocytes in vivo.

  2002cites this paper
• Establishment of a highly efficient gene transfer system for mouse fetal hepatic progenitor cells

  2002cites this paper
• Use of an adenoviral vector to express soluble donor-major histocompatibility complex molecules capable of suppressing the immune response in rat transplant recipients.

  2002cites this paper
• Soluble allogeneic MHC class I molecule gene transfer promotes CTL apoptosis in vivo.

  2001cites this paper
• Soluble donor MHC class I gene therapy prevents accelerated heart allograft rejection in actively sensitized rat recipients.

  2001cites this paper